Research Interest: Biotechnology, Vaccines, Vaccine Development, Virology, Viral Vaccines.

Research Interest: Gene therapy, Cell and tissue engineering, Vaccine development, Biomaterials, Synthetic biology and biomass, Nanobiotechnology.

Research Interest: Virology/Microbiology, Biochemistry, Clinical Diagnostics, Molecular Biology, Protein Chemistry.

Research Interest: Complement system, Immunoassays, Proteomics, Biomarkers in diseases, Vaccines, T regulatory cells and diseases, Immunology of leprosy and tuberculosis.

Research Interest: Inflammation, Immunology, Innate immunity, Infection, Antimicrobial peptides
Lipid mediators.

Research Interest: Pathogenesis and Treatment of Melanoma, and in Part are directed at Developing Tools to Study Melanoma.

Research Interest: Microbiology and Immunology, Malaria Pathogenesis

Research Interest: Epigenetic regulation of virus or autoimmune diseases on host immune cells such as Treg, Th17 and innate lymphoid cells (ILCs).

Research Interest: Bacteria of the genus Staphylococcus, in particular the species S. aureus and virulence factors produced by this species. In the so far carried out research, the results of which were published in several peer-reviewed journals I analyzed:

1.The influence of leucocytotoxic and superantygenic virulence factors produced by S. aureus strains isolated from milk of cows with mastitis on the cytokine production and gene expression in bovine leukocyte cultures in vitro;
2. the impact of staphylococcal exotoxins on the process of phagocytosis in vitro;
3. the efficacy of treatment of mastitis by staphylococcal autovaccine;
4. the profile of resistance to methicillin of coagulase-negative staphylococci isolated from animals;
5. the profile of the genes encoding superantigens in S. aureus and S. xylosus isolates collected from cows;
6. the possibility of transfer of genes encoding superantigens between staphylococci occurring in the same mammary gland;
7. genetic relatedness of staphylococci isolated within a herd of animals;
8. the biological activity of staphylococcal exosecretions against leukocytes in vitro;
9. the impact of staphylococcal virulence factors on the morphology of leukocytes in vitro.
I also analyzed and published in the GenBank several new 16S rRNA gene sequences of bacteria representing different species of staphylococci, identified by PCR-RFLP analysis of gap gene. Furthermore, as a contributor I published in the GenBank the 16S rRNA gene sequences of bacterial isolates, which were unidentified based on the polymorphism of gap gene, of which at least two isolates represent new species or subspecies of the staphylococci.
The second direction of my research concerns the use of magnetic fields, in particular the rotating magnetic field to modify the functional parameters and pathogenicity potential of different species of microorganisms. At the present, I’m analyzing the influence of magnetic field on metabolic processes in microorganisms, both at the cellular and molecular level. As a continuation of my first research mainstream microorganism used in these studies is primarily S. aureus.

David A. Reardon, MD, is a Professor of Medicine at Harvard Medical School and currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute.

He previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center for eleven years. He completed his residency at John Hopkins Hospital in Maryland, USA and was awarded a fellowship at the University of Michigan. Dr. Reardon is an active researcher with special interests in the design and implementation of clinical trials for neuro-oncology and the preclinical evaluation of promising therapeutics for central nervous system tumors.

His work includes using innovative clinical therapeutic agents to improve outcome for patients with brain and spinal tumors, with particular focus on immunotherapeutics. He has also led investigations of molecular-targeting agents, anti-angiogenic reagents, cytotoxins and other biologically-based therapies.

Dr. Reardon has published over 290 peer-reviewed manuscripts. He received the R. Wayne Rundles Award for Excellence in Cancer Research as well as the Award for Excellence in Adult Clinical Research by the Society for Neuro-Oncology in 2015 and 2016. He also served as the tenth president of the Society for Neuro-Oncology from 2013-2015.

Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

Research Interest: Infectious diseases in animals, diagnostics, epidemiology, efficiency of vaccination programmes.

Research Interest: Diagnosis of fungal infections; Therapy of mycoses; Pathogenesis of fungal infection; Antifungal drug resistance; Fungal infection animal model; Genomics in medical mycology; Candida mucosal immunity; Infectious dermatosis; genodermatoses.

Research Interest: Immunology, chronic viral infections (hepatitis C virus, Kaposi's sarcoma herps virus), dendritic cells, B cells.

Research Interest: Inflammatory bowel diseases coeliac disease, Cystic fibrosis.